Stay updated with breaking news from Embecta Corp. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Plus: Memorial Sloan Kettering kickstarts $100M cancer research project Merck's sales up 17% to $49.7 billion in 2021 Columbia Care raises $185M to fund growth in NY, NJ
Becton, Dickinson and Co.'s board of directors has approved the company's diabetes spinoff, with a set date of April 1.
/PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced its board of directors has...
/PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that Embecta Corp. ("embecta"),...
/PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that Embecta Corp. ("embecta"),...